Status:
TERMINATED
Skin Cancer Oncology Radiation Evidence Registry
Lead Sponsor:
GenesisCare USA
Conditions:
Non-melanoma Skin Cancer
Eligibility:
All Genders
18-120 years
Brief Summary
To collect and analyze long term safety and efficacy outcomes of patients undergoing radiotherapy for non-melanoma skin cancer. A target of 400 VMAT-treated sites is set which is estimated to be ident...
Detailed Description
The Registry will collect information on key clinical indications and patient reported outcomes to assess the safety and efficacy of VMAT radiotherapy. Data that will be collected includes baseline da...
Eligibility Criteria
Inclusion
- Over 18 years of age
- Diagnosed with a treatable non-melanoma skin cancer by referring medical practitioner
- Eligible to be treated using widefield (\>50cm2) VMAT radiotherapy as determined by RO
- Patient has provided written informed consent.
Exclusion
- ♦ Patients who do not consent to their involvement in the Registry.
Key Trial Info
Start Date :
February 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2021
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04681456
Start Date
February 15 2021
End Date
May 6 2021
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GenesisCare USA
Fort Myers, Florida, United States, 33907